【製薬大手】自社開発の主力2品が業績けん引。海外収益化で先行。
日付 | 信用売残 (解説) | 信用買残 (解説) | 信用倍率 (解説) |
---|---|---|---|
2021/1/8 | 38,700 | 928,700 | 24.00 |
2020/12/30 | 52,000 | 914,000 | 17.58 |
2020/12/25 | 55,700 | 1,018,300 | 18.28 |
2020/12/18 | 45,500 | 998,000 | 21.93 |
2020/12/11 | 150,000 | 928,000 | 6.19 |
2020/12/4 | 156,200 | 794,200 | 5.08 |
2020/11/27 | 84,800 | 786,100 | 9.27 |
2020/11/20 | 33,800 | 819,500 | 24.25 |
2020/11/13 | 86,500 | 761,000 | 8.80 |
2020/11/6 | 188,600 | 453,600 | 2.41 |
2020/10/30 | 53,200 | 536,200 | 10.08 |
2020/10/23 | 63,800 | 505,700 | 7.93 |
2020/10/16 | 77,300 | 462,500 | 5.98 |
2020/10/9 | 81,700 | 324,000 | 3.97 |
2020/10/2 | 93,700 | 241,400 | 2.58 |
2020/9/25 | 138,600 | 250,300 | 1.81 |
2020/9/18 | 95,100 | 241,500 | 2.54 |
2020/9/11 | 88,000 | 299,800 | 3.41 |
2020/9/4 | 106,500 | 279,800 | 2.63 |
2020/8/28 | 103,800 | 332,000 | 3.20 |
2020/8/21 | 268,400 | 310,700 | 1.16 |
2020/8/14 | 281,400 | 250,300 | 0.89 |
2020/8/7 | 104,400 | 309,100 | 2.96 |
2020/7/31 | 91,600 | 314,800 | 3.44 |
2020/7/22 | 107,400 | 324,000 | 3.02 |
2020/7/17 | 98,600 | 386,700 | 3.92 |